PMID- 16045185 OWN - NLM STAT- MEDLINE DCOM- 20050830 LR - 20110726 IS - 0301-4894 (Print) IS - 0301-4894 (Linking) VI - 106 IP - 7 DP - 2005 Jul TI - [Treatment strategy for children with Wilms tumor]. PG - 422-6 AB - Wilms tumor has an excellent prognosis according to the findings of the National Wilms Tumor Study (NWTS). The NWTS has been aiming to reduce the intensity of treatment for low-risk groups. Pathologic assessment or statistical analysis has identified the appropriate staging system suited to this treatment regimen. The Japanese Wilms Tumor Study (JWiTS) has been following the NWTS-5 regimen to increase survival rates and tumor-free survival rates from 1996. This study aims to establish a central review system of pathology and to study the presence of WT1 mutation in tumor samples. In addition, JWiTS focuses on developing an online database that can be shared over the Internet. However, the prognosis in patients with malignant rhabdoid tumor of the kidney (MRTK) is still poor. JWiTS has started to consider a new regimen for MRTK. FAU - Fukuzawa, Masahiro AU - Fukuzawa M AD - Division of Pediatric Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. LA - jpn PT - English Abstract PT - Journal Article PT - Review PL - Japan TA - Nihon Geka Gakkai Zasshi JT - Nihon Geka Gakkai zasshi JID - 0405405 RN - 0 (WT1 Proteins) SB - IM MH - Child MH - Chromosomes, Human, Pair 16/genetics MH - Combined Modality Therapy MH - Genes, Wilms Tumor MH - Humans MH - Kidney Neoplasms/diagnosis/genetics/pathology/*therapy MH - Loss of Heterozygosity MH - Mutation MH - Neoplasm Staging MH - Randomized Controlled Trials as Topic MH - Survival Rate MH - WT1 Proteins/genetics MH - Wilms Tumor/diagnosis/genetics/pathology/*therapy RF - 19 EDAT- 2005/07/28 09:00 MHDA- 2005/09/01 09:00 CRDT- 2005/07/28 09:00 PHST- 2005/07/28 09:00 [pubmed] PHST- 2005/09/01 09:00 [medline] PHST- 2005/07/28 09:00 [entrez] PST - ppublish SO - Nihon Geka Gakkai Zasshi. 2005 Jul;106(7):422-6.